***Background.*** In the United States, surveillance of non-influenza severe acute respiratory illness (SARI) is not well established. The Minnesota Department of Health (MDH) is conducting pilot hospital-based surveillance to characterize SARI in adults and children year-round.

***Methods.*** SARI surveillance was implemented two hospitals (one pediatric, one general). Residual upper respiratory specimens, collected for diagnostic testing, were submitted to the MDH-Public Health Laboratory from December 2013 to February 2014. Specimens were tested for 22 viral and bacterial pathogens by real-time PCR. Admission records, including history and physical, were reviewed to identify patients meeting SARI case definition (cough, shortness of breath, or difficulty breathing, with or without fever), and medical records were reviewed to obtain demographic and clinical data on patients with submitted specimens.

***Results.*** Of known hospitalizations, 1,232 specimens were submitted. Pediatrics median age was 2.9 years (range X -- xx); adult median age was 45.3 years (range xx-xx). There were no detections of enterovirus, influenza B, coronavirus 229E, Bordetella, *Legionella pneumophila,* or mycoplasma all other detections are presented in the table. 204 (19%) pediatric patients had \>1 pathogen detected compared to 2 (2%) adult patients (p\< 0.01). The most common pediatric co-detection was RSV and rhinovirus (xx/204).

                              Pediatrics (n=1087) No. (%)   Adults (n=138) No. (%)   p-value
  --------------------------- ----------------------------- ------------------------ ---------
  Any pathogen detected       780 (71)                      48 (35)                  \<0.001
  RSV                         454 (42)                      6 (4)                    \<0.001
  Rhinovirus                  156 (14)                      2 (1)                    \<0.001
  Adenovirus                  98 (9)                        2 (1)                    0.002
  Influenza A                 63 (6)                        31 (22)                  \<0.001
  *Chlamydophila pneumonia*   3 (\<1)                       0                        NS
  Coronavirus HKU1            53 (5)                        0                        0.008
  Coronavirus NL63            38 (4)                        3 (2)                    NS
  Coronavirus OC43            33 (3)                        0                        0.038
  hMPV                        45 (4)                        2 (1)                    NS
  Parainfluenza 1             22 (2)                        1 (1)                    NS
  Parainfluenza 2             13 (1)                        0                        NS
  Parainfluenza 3             2 (\<1)                       0                        NS
  Parainfluenza 4             2 (\<1)                       0                        NS

NS=not significant; hMPV=human metapneumovirus

***Conclusion.*** MDH established a pilot surveillance effort for SARI at two hospitals. Pediatric patients were more likely than adults to have a pathogen detected and to have \> 1 pathogen detected. Data are helpful to inform the development of prevention and therapeutic interventions for respiratory infections.
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